slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 14,8 mln. 13,74 mln. | Omzet 2025 * | 19,28 mln. 17,9 mln. | Marktkapitalisatie | 3,42 mln. 3,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -3 mln. -2,78 mln. | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | 0,23 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,18 x |
K/w-verhouding 2024 * |
-0,35
x | K/w-verhouding 2025 * |
3,8
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 0% |
Recentste transcriptie over NovaBay Pharmaceuticals, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 01-02-13 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 01-12-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 01-05-02 |
Yen You Zheng
BRD | Director/Board Member | 67 | 11-09-19 |
Bob Wu
BRD | Director/Board Member | 49 | 26-01-16 |